Opana Buyers' $145M Deal With $50M In Atty Fees Gets Final OK
By Nadia Dreid · November 4, 2022, 8:11 PM EDT
The attorneys who secured a $145 million settlement for direct purchasers of Endo Pharmaceuticals's Opana ER who said they overpaid generic-drug maker Impax Labs for the prescription painkiller because of a pay-for-delay deal will...
To view the full article, register now.